A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's Disease

• Status: Completed
• Trial end date: 2006-08-01
• Target enrollment: 0
• Participant gender: All

Summary

A study of infliximab in patients with Fistulizing Crohn's Disease

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Centocor, Inc.
• Treatments: Infliximab

Criteria

Inclusion Criteria:

• Single or multiple draining fistulas

• Crohn's disease of at least 3 months' duration,

Exclusion Criteria:

• Crohn's disease complications for which surgery might be indicated

• Positive stool culture